from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1650/pheT

LFCtreatmentdescriptionclass of inhibitor

-0.599

Amikacinug/mL Amikacintranslation

-0.235

Cap5-10ug/mL Capreomycintranslation

-1.687

Rox10-50 ug/mL Roxithromycintranslation

0.272

SM2-5 ug/mL Streptomycintranslation

-1.670

Tet5-10 ug/mL Tetracyclinetranslation

0.353

Rif0.2-5ug/mL Rifampicintranscription

0.625

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.946

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.656

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.730

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.957

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.484

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.811

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.777

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.924

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.535

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.568

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.537

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.662

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.694

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.471

KCN5-20 ug/mL Potassium cyaniderespiration

-0.383

NaN30.2-2 mM Sodium aziderespiration

0.193

Nigericin50 uM Nigericinrespiration

-0.548

TRC10-150 ug/mL Triclosanrespiration

-1.907

TRZ10-25 ug/mL Thioridazinerespiration

-0.634

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.730

menadione6-10 ug/mL Menadionerespiration

0.257

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.185

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.211

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.248

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.048

NRP_1Non-replicating persistence stage 1dosRassociated

0.222

Amp0.2mg/mL AmpicillincellWall

0.124

Cephalexin20-100 ug/mL CephalexincellWall

-0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

0.085

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.279

EMB10-20 ug/mL EthambutolcellWall

-0.109

Eta12-40 ug/mL EthionamidecellWall

0.243

INH0.2-0.4 ug/mL IsoniazidcellWall

0.137

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.184

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.026

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.554

BZA0.12 mg/mL BenzamidearomaticAmides

0.834

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.918

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.243

H2O24 mM hydrogen peroxideDNAdamaging

0.328

Levo10 ug/mL LevofloxacinDNAdamaging

0.959

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.449

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.140

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.827

UVUV-irradiationDNAdamaging

-1.197

ARP41-4 ug/mL Antitubercular compound ARP4?

0.328

Antimycin12.5-50 ug/mL Antimycin A?

0.061

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.966

PA_110-50 ug/mL Antitubercular compound PA-1?

1.006

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.737

PA8240.2-2 ug/mL PA-824?

-0.733

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.163

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.041

Verapamil50 uM Verapamil?

-0.097

mercaptoethanol2 mM 2-Mercaptoethanol?

0.043

methoxatin10-20 ug/mL Methoxatin?